{"id":"W2574969036","doi":"10.1182/blood.v110.11.2930.2930","title":"Synergistic Activity of the Novel Src/Abl Inhibitor Bosutinib in Combination with Imatinib.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Bosutinib; Imatinib; Imatinib mesylate; ABL; Dasatinib; Pharmacology; Cancer research; Myeloid leukemia; Chemistry; Nilotinib; Tyrosine kinase; Medicine; Receptor; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002346966,0.0004930248,0.0007567609,0.0005617437,0.0001654742,0.0003553346,0.0002260724,0.0002122548,0.001453298],"category_scores_gemma":[0.0001979334,0.0001511094,0.00036827,0.00045206,0.0001521266,0.0001700849,0.000352815,0.0004146899,0.0003469735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002119149,"about_ca_system_score_gemma":0.0002595202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003376679,"about_ca_topic_score_gemma":0.001283386,"domain_scores_codex":[0.9997125,0.00009850903,0.00002173514,0.00003808063,0.00008083272,0.00004837378],"domain_scores_gemma":[0.9999382,0.00001368804,0.00001366899,0.000005511236,0.000008594488,0.00002020554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003494713,0.001158554,0.001533072,0.0006714205,0.0002364747,0.0003440912,0.00007557314,0.002359917,0.9381992,0.0003230716,0.001306388,0.05029752],"study_design_scores_gemma":[0.0009589697,0.02249882,0.01557032,0.00007785312,0.0007288493,0.001804305,0.000083842,0.007448686,0.9230454,0.0001700905,0.02755221,0.00006067905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694309,0.01949177,0.002025861,0.0003026276,0.0002942113,0.0002353279,0.0006283286,0.00012802,0.007463021],"genre_scores_gemma":[0.9925104,0.003794515,0.00175143,0.0000650221,0.00006335754,0.00007707094,0.0004304695,0.00001356727,0.001294164],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001453298,"threshold_uncertainty_score":0.004861832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01312824758844625,"score_gpt":0.2557750856804566,"score_spread":0.2426468380920103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}